| Application no. and date | 19773583.0 (espacenet) (Federated) (European Patent Register), 20190903 | | Patent/reg. no. and date | DK/EP 3846810, 20231018 | | Publication date | 20210714 | | Priority no. and date | US 201862726585 P, 20180904 | | EP pub. no. and date |
EP 3846810 20210714 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V465876DK00 | | Inventor | CONLEY, Robert Russell, c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
DAVAR, Gudarz, c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
JOHNSON, Kirk Willis, c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/444 (2006.01) , A61P 25/06 (2006.01) | | Title | KRONISK AFTENDOSERING AF LASMIDITAN FOR MIGRÆNEFOREBYGGELSE | | Int. application no. | US2019049340 | | Int. publication no. | WO2020051137 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
